Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells-Reference-Cited by-同舟云学术

Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells

Published:2007-01-22 Issue:28 Volume:26 Page:4106-4114
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Jiang X,Ellison S J,Alarid E T,Shapiro D J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1210197.pdf

Reference48 articles.

1. Andrade F, Roy S, Nicholson D, Thornberry N, Rosen A, Casciola-Rosen L . (1998). Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity 8: 451–460.

2. Barrie MB, Stout HW, Abougergi MS, Miller BC, Thiele DL . (2004). Antiviral cytokines induce hepatic expression of the granzyme B inhibitors, proteinase inhibitor 9 and serine proteinase inhibitor 6. J Immunol 172: 6453–6459.

3. Bird CH, Sutton VR, Sun J, Hirst CE, Novak A, Kumar S et al. (1998). Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol Cell Biol 18: 6387–6398.

4. Blomberg K, Hautala R, Lovgren J, Mukkala VM, Lindqvist C, Akerman K . (1996). Time-resolved fluorometric assay for natural killer activity using target cells labelled with a fluorescence enhancing ligand. J Immunol Methods 193: 199–206.

5. Bots M, Kolfschoten IG, Bres SA, Rademaker MT, de Roo GM, Kruse M et al. (2005). SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicity. Blood 105: 1153–1161.

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The biological function of Serpinb9 and Serpinb9-based therapy;Frontiers in Immunology;2024-06-20

2. Signaling by Type I Interferons in Immune Cells: Disease Consequences;Cancers;2024-04-22

3. The Role of Estrogen and Estrogen Receptors in Head and Neck Tumors;Cancers;2024-04-19

4. The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy;Journal of the National Cancer Center;2024-03

5. Experimental and clinical evidence in favour of an effective immune stimulation in ER-positive, endocrine-dependent metastatic breast cancer;Frontiers in Immunology;2024-01-25